[Preclinical evaluation of a new camptothecin derivative, CPT-11, on the subrenal capsule assay]. 1987

Y Wang, and K Inoue, and H Shibata, and Y Itoh, and S C Chen, and M Ogawa

CPT-11 is a new derivative of camptothecin, a plant alkaloid developed in Japan. We investigated the antitumor activity of CPT-11 on the subrenal capsule assay by using 39 tumor samples from patients with various tumors. The overall chemosensitivity rate of CPT-11 was 44% and the mean tumor growth inhibition rate was 44% in all the tumors. In 18 ovarian cancer cases, the chemosensitivity rate was 56% and the mean tumor growth inhibition rate was 46%. The antitumor activity obtained by CPT-11 is comparable to that of adriamycin, cyclophosphamide and 5-fluorouracil in the same assay system. Based upon these results, CPT-11 is considered to be a good candidate for clinical trials.

UI MeSH Term Description Entries
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002166 Camptothecin An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity. Camptothecine
D003114 Colony-Forming Units Assay A cytologic technique for measuring the functional capacity of stem cells by assaying their activity. Clonogenic Cell Assay,Stem Cell Assay,Clonogenic Cell Assays,Colony Forming Units Assays,Colony-Forming Units Assays,Stem Cell Assays,Assay, Clonogenic Cell,Assay, Colony-Forming Units,Assay, Stem Cell,Assays, Clonogenic Cell,Assays, Colony-Forming Units,Assays, Stem Cell,Colony Forming Units Assay
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005260 Female Females
D000077146 Irinotecan A semisynthetic camptothecin derivative that inhibits DNA TOPOISOMERASE I to prevent nucleic acid synthesis during S PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS. 7-Ethyl-10-hydroxycamptothecin,CPT 11,CPT-11,Camptosar,Camptothecin-11,Irinotecan Hydrochloride,Irrinotecan,NK012 Compound,SN 38,SN 38 11,SN-38,SN-38-11,7 Ethyl 10 hydroxycamptothecin,CPT11,Camptothecin 11,SN3811
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics
D014410 Tumor Stem Cell Assay A cytologic technique for measuring the functional capacity of tumor stem cells by assaying their activity. It is used primarily for the in vitro testing of antineoplastic agents. Clonogenic Cell Assay, Tumor,Colony-Forming Units Assay, Tumor,Neoplasm Stem Cell Assay,Stem Cell Assay, Tumor,Colony Forming Units Assay, Tumor

Related Publications

Y Wang, and K Inoue, and H Shibata, and Y Itoh, and S C Chen, and M Ogawa
May 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Y Wang, and K Inoue, and H Shibata, and Y Itoh, and S C Chen, and M Ogawa
January 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Wang, and K Inoue, and H Shibata, and Y Itoh, and S C Chen, and M Ogawa
August 1991, Cancer research,
Y Wang, and K Inoue, and H Shibata, and Y Itoh, and S C Chen, and M Ogawa
January 1988, Cancer chemotherapy and pharmacology,
Y Wang, and K Inoue, and H Shibata, and Y Itoh, and S C Chen, and M Ogawa
February 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Wang, and K Inoue, and H Shibata, and Y Itoh, and S C Chen, and M Ogawa
June 1995, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
Y Wang, and K Inoue, and H Shibata, and Y Itoh, and S C Chen, and M Ogawa
April 1987, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
Y Wang, and K Inoue, and H Shibata, and Y Itoh, and S C Chen, and M Ogawa
May 1991, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Wang, and K Inoue, and H Shibata, and Y Itoh, and S C Chen, and M Ogawa
March 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Wang, and K Inoue, and H Shibata, and Y Itoh, and S C Chen, and M Ogawa
August 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Copied contents to your clipboard!